Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance

BACKGROUND: Tuberculosis (TB) is the world’s leading infectious cause of death. Extrapulmonary TB accounts for 15% of TB cases, but the proportion is increasing, and over half a million people were newly diagnosed with rifampicin‐resistant TB in 2016. Xpert(®) MTB/RIF (Xpert) is a World Health Organ...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Kohli, Mikashmi, Schiller, Ian, Dendukuri, Nandini, Dheda, Keertan, Denkinger, Claudia M, Schumacher, Samuel G, Steingart, Karen R
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2018
Témata:
Medicine General & Introductory Medical Sciences
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513199/
https://ncbi.nlm.nih.gov/pubmed/30148542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012768.pub2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky